Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 60 entries
Sorted by: Best Match Show Resources per page
A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

Orsini A, Foiadelli T, Magistrali M, Carli N, Bagnasco I, Dassi P, Verrotti A, Marcotulli D, Canavese C, Nicita F, Capuano A, Marra C, Fetta A, Nosadini M, Sartori S, Papa A, Viri M, Greco F, Pavone P, Simonini G, Matricardi S, Siquilini S, Marchese F, De Grandis E, Brunenghi BM, Malattia C, Bassanese F, Bergonzini P, Bonuccelli A, Consolini R, Marseglia GL, Peroni D, Striano P, Cordelli D, Savasta S.
PMID: 34768201
Eur J Paediatr Neurol. 2021 Nov 06;36:1-6. doi: 10.1016/j.ejpn.2021.11.002. Epub 2021 Nov 06.

OBJECTIVES: Sydenham's Chorea (SC) is a neuropsychiatric disorder and a major manifestation of acute rheumatic fever. The erroneous assumption that SC is a benign and self-limiting disease, has led to a lack of high-quality scientific evidence of the therapeutical...

Cite
Orsini A, Foiadelli T, Magistrali M, et al. A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors. Eur J Paediatr Neurol. 2021;36:1-6doi: 10.1016/j.ejpn.2021.11.002.
Orsini, A., Foiadelli, T., Magistrali, M., Carli, N., Bagnasco, I., Dassi, P., Verrotti, A., Marcotulli, D., Canavese, C., Nicita, F., Capuano, A., Marra, C., Fetta, A., Nosadini, M., Sartori, S., Papa, A., Viri, M., Greco, F., Pavone, P., Simonini, G., Matricardi, S., Siquilini, S., Marchese, F., De Grandis, E., Brunenghi, B. M., Malattia, C., Bassanese, F., Bergonzini, P., Bonuccelli, A., Consolini, R., Marseglia, G. L., Peroni, D., Striano, P., Cordelli, D., & Savasta, S. (2021). A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 361-6. https://doi.org/10.1016/j.ejpn.2021.11.002
Orsini, Alessandro, et al. "A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors." European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society vol. 36 (2021): 1-6. doi: https://doi.org/10.1016/j.ejpn.2021.11.002
Orsini A, Foiadelli T, Magistrali M, Carli N, Bagnasco I, Dassi P, Verrotti A, Marcotulli D, Canavese C, Nicita F, Capuano A, Marra C, Fetta A, Nosadini M, Sartori S, Papa A, Viri M, Greco F, Pavone P, Simonini G, Matricardi S, Siquilini S, Marchese F, De Grandis E, Brunenghi BM, Malattia C, Bassanese F, Bergonzini P, Bonuccelli A, Consolini R, Marseglia GL, Peroni D, Striano P, Cordelli D, Savasta S. A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors. Eur J Paediatr Neurol. 2021 Nov 06;36:1-6. doi: 10.1016/j.ejpn.2021.11.002. Epub 2021 Nov 06. PMID: 34768201.
Copy Download .nbib Format: NLM
Schizophrenia and Macroprolactinoma: Is There a Deep Link?.

Advanced biomedical research

Bamarinejad A, Nasiri S, Bamarinejad F, Salehidoost R, Zare-Farashbandi E.
PMID: 33072650
Adv Biomed Res. 2020 Aug 28;9:38. doi: 10.4103/abr.abr_96_20. eCollection 2020.

Prolactinomas are the most common type of functional pituitary tumors. Dopamine agonists is the most important drugs used in prolactinoma,have antagonistic effect with antipsychotic drugs used in schizophrenia. Conversely, dopamine antagonist drugs increase prolactin in patients with simultaneous schizophrenia....

Cite
Bamarinejad A, Nasiri S, Bamarinejad F, et al. Schizophrenia and Macroprolactinoma: Is There a Deep Link?. Adv Biomed Res. 2020;9:38doi: 10.4103/abr.abr_96_20.
Bamarinejad, A., Nasiri, S., Bamarinejad, F., Salehidoost, R., & Zare-Farashbandi, E. (2020). Schizophrenia and Macroprolactinoma: Is There a Deep Link?. Advanced biomedical research, 938. https://doi.org/10.4103/abr.abr_96_20
Bamarinejad, Atefeh, et al. "Schizophrenia and Macroprolactinoma: Is There a Deep Link?." Advanced biomedical research vol. 9 (2020): 38. doi: https://doi.org/10.4103/abr.abr_96_20
Bamarinejad A, Nasiri S, Bamarinejad F, Salehidoost R, Zare-Farashbandi E. Schizophrenia and Macroprolactinoma: Is There a Deep Link?. Adv Biomed Res. 2020 Aug 28;9:38. doi: 10.4103/abr.abr_96_20. eCollection 2020. PMID: 33072650; PMCID: PMC7532829.
Copy Download .nbib Format: NLM
Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release.

British journal of pharmacology

Thomson K, Kelly T, Karouta C, Morgan I, Ashby R.
PMID: 34302355
Br J Pharmacol. 2021 Nov;178(22):4501-4517. doi: 10.1111/bph.15629. Epub 2021 Oct 10.

BACKGROUND AND PURPOSE: The ability of the muscarinic cholinergic antagonist atropine to inhibit myopia development in humans and animal models would suggest that cholinergic hyperactivity may underlie myopic growth. To test this, we investigated whether cholinergic agonists accelerate ocular...

Cite
Thomson K, Kelly T, Karouta C, et al. Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release. Br J Pharmacol. 2021;178(22):4501-4517doi: 10.1111/bph.15629.
Thomson, K., Kelly, T., Karouta, C., Morgan, I., & Ashby, R. (2021). Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release. British journal of pharmacology, 178(22), 4501-4517. https://doi.org/10.1111/bph.15629
Thomson, Kate, et al. "Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release." British journal of pharmacology vol. 178,22 (2021): 4501-4517. doi: https://doi.org/10.1111/bph.15629
Thomson K, Kelly T, Karouta C, Morgan I, Ashby R. Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release. Br J Pharmacol. 2021 Nov;178(22):4501-4517. doi: 10.1111/bph.15629. Epub 2021 Oct 10. PMID: 34302355.
Copy Download .nbib Format: NLM
Lateralized semantic priming: modulation by levodopa, semantic distance, and participants' magical beliefs.

Neuropsychiatric disease and treatment

Mohr C, Landis T, Brugger P.
PMID: 19412448
Neuropsychiatr Dis Treat. 2006 Mar;2(1):71-84.

We tested levodopa effects on lateralized direct and indirect semantic priming in 40 healthy right-handed men in a placebo-controlled, double-blind procedure. Crucially, priming was also analyzed as a function of participants' positive schizotypal features (magical ideation, MI), previously found...

Cite
Mohr C, Landis T, Brugger P. Lateralized semantic priming: modulation by levodopa, semantic distance, and participants' magical beliefs. Neuropsychiatr Dis Treat. 2006;2(1):71-84
Mohr, C., Landis, T., & Brugger, P. (2006). Lateralized semantic priming: modulation by levodopa, semantic distance, and participants' magical beliefs. Neuropsychiatric disease and treatment, 2(1), 71-84.
Mohr, Christine, et al. "Lateralized semantic priming: modulation by levodopa, semantic distance, and participants' magical beliefs." Neuropsychiatric disease and treatment vol. 2,1 (2006): 71-84.
Mohr C, Landis T, Brugger P. Lateralized semantic priming: modulation by levodopa, semantic distance, and participants' magical beliefs. Neuropsychiatr Dis Treat. 2006 Mar;2(1):71-84. PMID: 19412448; PMCID: PMC2671739.
Copy Download .nbib Format: NLM
A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

Orsini A, Foiadelli T, Magistrali M, Carli N, Bagnasco I, Dassi P, Verrotti A, Marcotulli D, Canavese C, Nicita F, Capuano A, Marra C, Fetta A, Nosadini M, Sartori S, Papa A, Viri M, Greco F, Pavone P, Simonini G, Matricardi S, Siquilini S, Marchese F, De Grandis E, Brunenghi BM, Malattia C, Bassanese F, Bergonzini P, Bonuccelli A, Consolini R, Marseglia GL, Peroni D, Striano P, Cordelli D, Savasta S.
PMID: 34768201
Eur J Paediatr Neurol. 2021 Nov 06;36:1-6. doi: 10.1016/j.ejpn.2021.11.002. Epub 2021 Nov 06.

OBJECTIVES: Sydenham's Chorea (SC) is a neuropsychiatric disorder and a major manifestation of acute rheumatic fever. The erroneous assumption that SC is a benign and self-limiting disease, has led to a lack of high-quality scientific evidence of the therapeutical...

Cite
Orsini A, Foiadelli T, Magistrali M, et al. A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors. Eur J Paediatr Neurol. 2021;36:1-6doi: 10.1016/j.ejpn.2021.11.002.
Orsini, A., Foiadelli, T., Magistrali, M., Carli, N., Bagnasco, I., Dassi, P., Verrotti, A., Marcotulli, D., Canavese, C., Nicita, F., Capuano, A., Marra, C., Fetta, A., Nosadini, M., Sartori, S., Papa, A., Viri, M., Greco, F., Pavone, P., Simonini, G., Matricardi, S., Siquilini, S., Marchese, F., De Grandis, E., Brunenghi, B. M., Malattia, C., Bassanese, F., Bergonzini, P., Bonuccelli, A., Consolini, R., Marseglia, G. L., Peroni, D., Striano, P., Cordelli, D., & Savasta, S. (2021). A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 361-6. https://doi.org/10.1016/j.ejpn.2021.11.002
Orsini, Alessandro, et al. "A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors." European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society vol. 36 (2021): 1-6. doi: https://doi.org/10.1016/j.ejpn.2021.11.002
Orsini A, Foiadelli T, Magistrali M, Carli N, Bagnasco I, Dassi P, Verrotti A, Marcotulli D, Canavese C, Nicita F, Capuano A, Marra C, Fetta A, Nosadini M, Sartori S, Papa A, Viri M, Greco F, Pavone P, Simonini G, Matricardi S, Siquilini S, Marchese F, De Grandis E, Brunenghi BM, Malattia C, Bassanese F, Bergonzini P, Bonuccelli A, Consolini R, Marseglia GL, Peroni D, Striano P, Cordelli D, Savasta S. A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors. Eur J Paediatr Neurol. 2021 Nov 06;36:1-6. doi: 10.1016/j.ejpn.2021.11.002. Epub 2021 Nov 06. PMID: 34768201.
Copy Download .nbib Format: NLM
Optimal management strategies for primary headache in the emergency department.

CJEM

Wells S, Stiell IG, Vishnyakova E, Lun R, Nemnom MJ, Perry JJ.
PMID: 34390484
CJEM. 2021 Nov;23(6):802-811. doi: 10.1007/s43678-021-00173-0. Epub 2021 Aug 14.

PURPOSE: We sought to evaluate the factors associated with better outcomes for emergency department (ED) patients treated for primary headache.METHODS: This was a health records review of consecutive patients over a 3-month period presenting to two tertiary EDs and...

Cite
Wells S, Stiell IG, Vishnyakova E, et al. Optimal management strategies for primary headache in the emergency department. CJEM. 2021;23(6):802-811doi: 10.1007/s43678-021-00173-0.
Wells, S., Stiell, I. G., Vishnyakova, E., Lun, R., Nemnom, M. J., & Perry, J. J. (2021). Optimal management strategies for primary headache in the emergency department. CJEM, 23(6), 802-811. https://doi.org/10.1007/s43678-021-00173-0
Wells, Simon, et al. "Optimal management strategies for primary headache in the emergency department." CJEM vol. 23,6 (2021): 802-811. doi: https://doi.org/10.1007/s43678-021-00173-0
Wells S, Stiell IG, Vishnyakova E, Lun R, Nemnom MJ, Perry JJ. Optimal management strategies for primary headache in the emergency department. CJEM. 2021 Nov;23(6):802-811. doi: 10.1007/s43678-021-00173-0. Epub 2021 Aug 14. PMID: 34390484.
Copy Download .nbib Format: NLM
Sydenham's chorea: from pathophysiology to therapeutics.

Expert review of neurotherapeutics

Teixeira AL, Vasconcelos LP, Nunes MDCP, Singer H.
PMID: 34353207
Expert Rev Neurother. 2021 Aug;21(8):913-922. doi: 10.1080/14737175.2021.1965883. Epub 2021 Aug 18.

Sydenham's chorea is an autoimmune chorea emerging after a group A beta-hemolytic streptococcal (GABHS) infection, i.e. a rheumatic chorea with or without the presence of carditis or arthritis. The disorder, defined by the presence of chorea, is also associated...

Cite
Teixeira AL, Vasconcelos LP, Nunes MDCP, et al. Sydenham's chorea: from pathophysiology to therapeutics. Expert Rev Neurother. 2021;21(8):913-922doi: 10.1080/14737175.2021.1965883.
Teixeira, A. L., Vasconcelos, L. P., Nunes, M. D. C. P., & Singer, H. (2021). Sydenham's chorea: from pathophysiology to therapeutics. Expert review of neurotherapeutics, 21(8), 913-922. https://doi.org/10.1080/14737175.2021.1965883
Teixeira, Antonio L, et al. "Sydenham's chorea: from pathophysiology to therapeutics." Expert review of neurotherapeutics vol. 21,8 (2021): 913-922. doi: https://doi.org/10.1080/14737175.2021.1965883
Teixeira AL, Vasconcelos LP, Nunes MDCP, Singer H. Sydenham's chorea: from pathophysiology to therapeutics. Expert Rev Neurother. 2021 Aug;21(8):913-922. doi: 10.1080/14737175.2021.1965883. Epub 2021 Aug 18. PMID: 34353207.
Copy Download .nbib Format: NLM
Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study.

Human psychopharmacology

Ishigooka J, Inada K, Niidome K, Aoki K, Kojima Y, Iwashita S, Yamada S.
PMID: 33496984
Hum Psychopharmacol. 2021 Jul;36(4):e2777. doi: 10.1002/hup.2777. Epub 2021 Jan 26.

OBJECTIVES: To determine the long-term safety of switching to brexpiprazole from aripiprazole or non-aripiprazole dopamine antagonists.METHODS: Post-hoc analysis of 56-week study of Japanese outpatients with schizophrenia switched to brexpiprazole 2 mg/day over 4-week switching period with further titration (1-4...

Cite
Ishigooka J, Inada K, Niidome K, et al. Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study. Hum Psychopharmacol. 2021;36(4):e2777doi: 10.1002/hup.2777.
Ishigooka, J., Inada, K., Niidome, K., Aoki, K., Kojima, Y., Iwashita, S., & Yamada, S. (2021). Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study. Human psychopharmacology, 36(4), e2777. https://doi.org/10.1002/hup.2777
Ishigooka, Jun, et al. "Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study." Human psychopharmacology vol. 36,4 (2021): e2777. doi: https://doi.org/10.1002/hup.2777
Ishigooka J, Inada K, Niidome K, Aoki K, Kojima Y, Iwashita S, Yamada S. Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study. Hum Psychopharmacol. 2021 Jul;36(4):e2777. doi: 10.1002/hup.2777. Epub 2021 Jan 26. PMID: 33496984; PMCID: PMC8365679.
Copy Download .nbib Format: NLM
A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

Orsini A, Foiadelli T, Magistrali M, Carli N, Bagnasco I, Dassi P, Verrotti A, Marcotulli D, Canavese C, Nicita F, Capuano A, Marra C, Fetta A, Nosadini M, Sartori S, Papa A, Viri M, Greco F, Pavone P, Simonini G, Matricardi S, Siquilini S, Marchese F, De Grandis E, Brunenghi BM, Malattia C, Bassanese F, Bergonzini P, Bonuccelli A, Consolini R, Marseglia GL, Peroni D, Striano P, Cordelli D, Savasta S.
PMID: 34768201
Eur J Paediatr Neurol. 2021 Nov 06;36:1-6. doi: 10.1016/j.ejpn.2021.11.002. Epub 2021 Nov 06.

OBJECTIVES: Sydenham's Chorea (SC) is a neuropsychiatric disorder and a major manifestation of acute rheumatic fever. The erroneous assumption that SC is a benign and self-limiting disease, has led to a lack of high-quality scientific evidence of the therapeutical...

Cite
Orsini A, Foiadelli T, Magistrali M, et al. A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors. Eur J Paediatr Neurol. 2021;36:1-6doi: 10.1016/j.ejpn.2021.11.002.
Orsini, A., Foiadelli, T., Magistrali, M., Carli, N., Bagnasco, I., Dassi, P., Verrotti, A., Marcotulli, D., Canavese, C., Nicita, F., Capuano, A., Marra, C., Fetta, A., Nosadini, M., Sartori, S., Papa, A., Viri, M., Greco, F., Pavone, P., Simonini, G., Matricardi, S., Siquilini, S., Marchese, F., De Grandis, E., Brunenghi, B. M., Malattia, C., Bassanese, F., Bergonzini, P., Bonuccelli, A., Consolini, R., Marseglia, G. L., Peroni, D., Striano, P., Cordelli, D., & Savasta, S. (2021). A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 361-6. https://doi.org/10.1016/j.ejpn.2021.11.002
Orsini, Alessandro, et al. "A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors." European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society vol. 36 (2021): 1-6. doi: https://doi.org/10.1016/j.ejpn.2021.11.002
Orsini A, Foiadelli T, Magistrali M, Carli N, Bagnasco I, Dassi P, Verrotti A, Marcotulli D, Canavese C, Nicita F, Capuano A, Marra C, Fetta A, Nosadini M, Sartori S, Papa A, Viri M, Greco F, Pavone P, Simonini G, Matricardi S, Siquilini S, Marchese F, De Grandis E, Brunenghi BM, Malattia C, Bassanese F, Bergonzini P, Bonuccelli A, Consolini R, Marseglia GL, Peroni D, Striano P, Cordelli D, Savasta S. A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors. Eur J Paediatr Neurol. 2021 Nov 06;36:1-6. doi: 10.1016/j.ejpn.2021.11.002. Epub 2021 Nov 06. PMID: 34768201.
Copy Download .nbib Format: NLM
Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies.

Cancer biology & medicine

Yeo W, Li L, Lau TK, Lai KT, Chan VT, Wong KH, Yip CC, Pang E, Cheung M, Chan V, Kwok CC, Suen JJ, Mo FK.
PMID: 33710814
Cancer Biol Med. 2021 Mar 12; doi: 10.20892/j.issn.2095-3941.2020.0241. Epub 2021 Mar 12.

OBJECTIVE: Chemotherapy-induced nausea and vomiting (CINV) are common with doxorubicin-cyclophosphamide (AC) chemotherapy. Recommended antiemetic regimens incorporate neurokinin-1 receptor antagonist (NK1RA), 5-hydroxytryptamine type-3 receptor antagonist (5HT3RA), corticosteroid, and dopamine antagonists. This post-hoc analysis compared results of 3 prospective antiemetic studies...

Cite
Yeo W, Li L, Lau TK, et al. Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies. Cancer Biol Med. 2021;doi: 10.20892/j.issn.2095-3941.2020.0241.
Yeo, W., Li, L., Lau, T. K., Lai, K. T., Chan, V. T., Wong, K. H., Yip, C. C., Pang, E., Cheung, M., Chan, V., Kwok, C. C., Suen, J. J., & Mo, F. K. (2021). Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies. Cancer biology & medicine, . https://doi.org/10.20892/j.issn.2095-3941.2020.0241
Yeo, Winnie, et al. "Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies." Cancer biology & medicine vol. (2021). doi: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
Yeo W, Li L, Lau TK, Lai KT, Chan VT, Wong KH, Yip CC, Pang E, Cheung M, Chan V, Kwok CC, Suen JJ, Mo FK. Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies. Cancer Biol Med. 2021 Mar 12; doi: 10.20892/j.issn.2095-3941.2020.0241. Epub 2021 Mar 12. PMID: 33710814; PMCID: PMC8330523.
Copy Download .nbib Format: NLM
Opposed Behavioural Outputs of Increased Dopamine Transmission in Prefrontocortical and Subcortical Areas: A Role for the Cortical D-1 Dopamine Receptor.

The European journal of neuroscience

Vezina P, Blanc G, Glowinski J, Tassin JP.
PMID: 12106258
Eur J Neurosci. 1991;3(10):1001-1007. doi: 10.1111/j.1460-9568.1991.tb00036.x.

The possibility that the dopaminergic neurons innervating the medial prefrontal cortex (mPFC) can inhibit locomotor behaviour has been suggested in several studies. The evidence remains indirect, however, because the manipulations tested aimed exclusively at permanently depleting mPFC dopamine. Here...

Cite
Vezina P, Blanc G, Glowinski J, et al. Opposed Behavioural Outputs of Increased Dopamine Transmission in Prefrontocortical and Subcortical Areas: A Role for the Cortical D-1 Dopamine Receptor. Eur J Neurosci. 1991;3(10):1001-1007doi: 10.1111/j.1460-9568.1991.tb00036.x.
Vezina, P., Blanc, G., Glowinski, J., & Tassin, J. P. (1991). Opposed Behavioural Outputs of Increased Dopamine Transmission in Prefrontocortical and Subcortical Areas: A Role for the Cortical D-1 Dopamine Receptor. The European journal of neuroscience, 3(10), 1001-1007. https://doi.org/10.1111/j.1460-9568.1991.tb00036.x
Vezina, P., et al. "Opposed Behavioural Outputs of Increased Dopamine Transmission in Prefrontocortical and Subcortical Areas: A Role for the Cortical D-1 Dopamine Receptor." The European journal of neuroscience vol. 3,10 (1991): 1001-1007. doi: https://doi.org/10.1111/j.1460-9568.1991.tb00036.x
Vezina P, Blanc G, Glowinski J, Tassin JP. Opposed Behavioural Outputs of Increased Dopamine Transmission in Prefrontocortical and Subcortical Areas: A Role for the Cortical D-1 Dopamine Receptor. Eur J Neurosci. 1991;3(10):1001-1007. doi: 10.1111/j.1460-9568.1991.tb00036.x. PMID: 12106258.
Copy Download .nbib Format: NLM
The role of D1-dopamine receptors in working memory-guided movements mediated by frontal cortical areas.

Parkinsonism & related disorders

Sawaguchi T.
PMID: 11008191
Parkinsonism Relat Disord. 2000 Nov 01;7(1):9-19. doi: 10.1016/s1353-8020(00)00044-4.

Like the striatum, the frontal motor cortices receive dopaminergic fibers from midbrain dopamine cells and contain high levels of dopamine receptors. Among frontal cortical areas, the dorsolateral PFC (PFd1) and the dorsal premotor cortex (PMd) have strong neural connections...

Cite
Sawaguchi T. The role of D1-dopamine receptors in working memory-guided movements mediated by frontal cortical areas. Parkinsonism Relat Disord. 2000;7(1):9-19doi: 10.1016/s1353-8020(00)00044-4.
Sawaguchi, T. (2000). The role of D1-dopamine receptors in working memory-guided movements mediated by frontal cortical areas. Parkinsonism & related disorders, 7(1), 9-19. https://doi.org/10.1016/s1353-8020(00)00044-4
Sawaguchi. "The role of D1-dopamine receptors in working memory-guided movements mediated by frontal cortical areas." Parkinsonism & related disorders vol. 7,1 (2000): 9-19. doi: https://doi.org/10.1016/s1353-8020(00)00044-4
Sawaguchi T. The role of D1-dopamine receptors in working memory-guided movements mediated by frontal cortical areas. Parkinsonism Relat Disord. 2000 Nov 01;7(1):9-19. doi: 10.1016/s1353-8020(00)00044-4. PMID: 11008191.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 60 entries